PE20070109A1 - Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina - Google Patents

Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina

Info

Publication number
PE20070109A1
PE20070109A1 PE2006000628A PE2006000628A PE20070109A1 PE 20070109 A1 PE20070109 A1 PE 20070109A1 PE 2006000628 A PE2006000628 A PE 2006000628A PE 2006000628 A PE2006000628 A PE 2006000628A PE 20070109 A1 PE20070109 A1 PE 20070109A1
Authority
PE
Peru
Prior art keywords
methyl
imidazol
trifluoromethyl
benzenamine
synthesis
Prior art date
Application number
PE2006000628A
Other languages
English (en)
Spanish (es)
Inventor
Stephan Abel
Murat Acemoglu
Christoph Krell
Mark Meisenbach
Wen-Chung Shieh
Song Xue
Mahavir Prashad
Joseph Sclafani
Bernhard Erb
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20070109(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20070109A1 publication Critical patent/PE20070109A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PE2006000628A 2005-06-09 2006-06-07 Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina PE20070109A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
PE20070109A1 true PE20070109A1 (es) 2007-04-02

Family

ID=37149980

Family Applications (3)

Application Number Title Priority Date Filing Date
PE2010000467A PE20100715A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina
PE2006000628A PE20070109A1 (es) 2005-06-09 2006-06-07 Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina
PE2010000468A PE20100716A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2010000467A PE20100715A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2010000468A PE20100716A1 (es) 2005-06-09 2006-06-07 Proceso para la sintesis de 1-bromo-3-nitro-5-trifluorometil-benceno

Country Status (25)

Country Link
US (2) US7781597B2 (enExample)
EP (3) EP2292607B1 (enExample)
JP (2) JP5225078B2 (enExample)
KR (2) KR101249199B1 (enExample)
CN (6) CN102174021B (enExample)
AR (1) AR057056A1 (enExample)
AT (1) ATE540931T1 (enExample)
AU (3) AU2006258050B2 (enExample)
BR (1) BRPI0611683A2 (enExample)
CA (4) CA2942046A1 (enExample)
DK (2) DK2266961T3 (enExample)
ES (3) ES2465522T3 (enExample)
GT (1) GT200600202AA (enExample)
HU (1) HUE028024T2 (enExample)
IN (2) IN2014DN08588A (enExample)
JO (1) JO2758B1 (enExample)
MX (1) MX2007015609A (enExample)
MY (1) MY146795A (enExample)
PE (3) PE20100715A1 (enExample)
PL (3) PL2266961T3 (enExample)
PT (3) PT2292607E (enExample)
RU (1) RU2446162C2 (enExample)
SI (2) SI2266961T1 (enExample)
TW (1) TWI380981B (enExample)
WO (1) WO2006135640A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1930136B (zh) 2004-03-05 2012-02-08 日产化学工业株式会社 异*唑啉取代苯甲酰胺化合物及有害生物防除剂
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
BRPI0809770B8 (pt) 2007-06-13 2022-12-06 Du Pont Composto e composição para controlar uma praga de invertebrados
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
DK2957284T3 (en) 2007-06-27 2018-02-05 Du Pont PROCEDURE TO CHECK ANIMALS FOR ANIMALS
TWI600639B (zh) 2007-08-17 2017-10-01 杜邦股份有限公司 製備5-鹵烷基-4,5-二氫異唑衍生物之化合物
KR20100075996A (ko) 2007-10-03 2010-07-05 이 아이 듀폰 디 네모아 앤드 캄파니 무척추 해충의 방제를 위한 나프탈렌 이속사졸린 화합물
TWI583664B (zh) 2008-04-09 2017-05-21 杜邦股份有限公司 羰基化合物及其製備方法
US20100016590A1 (en) * 2008-07-17 2010-01-21 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
EP2530081A3 (en) 2008-11-05 2013-04-10 Teva Pharmaceutical Industries, Ltd. Nilotinib HCI crystalline forms
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
MX2012013758A (es) 2010-05-27 2013-01-24 Du Pont Forma cristalina de 4-[5-[3-cloro-5-trifluorometil)fenil]-4,5-dihi dro-5-(trifluorometil)-3-isoxazolil]-n-[2-oxo-2-[(2,2,2-trifluoro etil)amino]etil]-1-naftalenocarboxamida.
BR112014015720B1 (pt) 2011-12-30 2020-03-17 Hanmi Pharm. Co., Ltd. Derivados de tieno[3,2-d]pirimidina, composição farmacêutica e uso dos mesmos para a prevenção ou tratamento de uma doença causada por ativação anormal de uma proteína quinase
CN102592837B (zh) * 2012-03-12 2014-01-15 河北师范大学 制备超级电容器用四氯合金属季铵盐掺杂聚苯胺电极的方法
CN103694176B (zh) * 2014-01-07 2015-02-18 苏州立新制药有限公司 尼洛替尼中间体的制备方法
CN104592122B (zh) * 2014-12-09 2018-01-23 凯莱英医药集团(天津)股份有限公司 3‑(4‑甲基‑1h‑咪唑‑1‑基)‑5‑(三氟甲基)苯胺的制备方法
CN105985293B (zh) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 尼洛替尼中间体的制备方法
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (zh) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 芳香化合物的硝化方法
WO2019130254A1 (en) * 2018-01-01 2019-07-04 Laurus Labs Ltd An improved process for 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (zh) * 2018-04-10 2020-01-21 江苏创诺制药有限公司 一种3-(4-甲基-1h-咪唑-1-基)-5-三氟甲基苯胺单盐酸盐的晶型及其应用
EP3806858A4 (en) 2018-06-15 2022-03-09 Handa Pharmaceuticals, Inc. KINA INHIBITOR SALTS AND COMPOSITIONS THEREOF
US11014945B2 (en) * 2019-04-06 2021-05-25 Trinapco, Inc. Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836B (zh) * 2021-02-23 2024-05-31 四川青木制药有限公司 3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺合成方法及其中间体
CN114853734A (zh) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 一种尼洛替尼游离碱的制备方法
CN116478319B (zh) * 2022-11-07 2025-07-01 华北电力大学 一种离子共价有机聚合物的制备方法及其在碱性环境吸附ReO4-的应用
CN115626880B (zh) * 2022-11-15 2023-11-14 常州大学 3-硝基-5-氰基三氟甲苯的合成方法
CN118108670B (zh) * 2023-12-28 2025-07-01 江苏希迪制药有限公司 尼罗替尼中间体3-(4-甲基-1h-咪唑-1-基)-5-(三氟甲基)苯胺的精制纯化方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (ru) * 1982-04-09 1983-10-30 Алтайский политехнический институт Способ получени производных имидазола
CA1292234C (en) * 1984-05-29 1991-11-19 Simon Fraser Campbell Heterocyclic-substituted quinolone inotropic agents
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (es) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
PE20040522A1 (es) * 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (zh) * 2004-12-31 2007-04-04 孙飘扬 氨基嘧啶类化合物及其盐和其制备方法与药物用途
GT200600207A (es) * 2005-06-09 2007-01-15 Novartis Ag Proceso para la síntesis de compuestos orgánicos
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds

Also Published As

Publication number Publication date
HUE028024T2 (en) 2016-11-28
CN102174020A (zh) 2011-09-07
ES2558696T3 (es) 2016-02-08
PT1896426E (pt) 2012-04-12
CN102180796A (zh) 2011-09-14
MX2007015609A (es) 2008-02-25
PL2266961T3 (pl) 2016-04-29
AU2006258050B2 (en) 2010-12-09
CN102174021B (zh) 2013-02-27
US7781597B2 (en) 2010-08-24
KR101249199B1 (ko) 2013-04-03
CA2611280A1 (en) 2006-12-21
JP5225078B2 (ja) 2013-07-03
TW200716563A (en) 2007-05-01
RU2446162C2 (ru) 2012-03-27
JP2013035855A (ja) 2013-02-21
SI2292607T1 (sl) 2014-09-30
CN102180836A (zh) 2011-09-14
US20080200692A1 (en) 2008-08-21
PE20100715A1 (es) 2010-10-25
SI2266961T1 (sl) 2016-02-29
EP2292607A3 (en) 2011-04-27
JO2758B1 (en) 2014-03-15
ATE540931T1 (de) 2012-01-15
PL1896426T3 (pl) 2012-06-29
PE20100716A1 (es) 2010-10-25
CN102174019A (zh) 2011-09-07
ES2380489T8 (es) 2012-06-22
CN102174021A (zh) 2011-09-07
EP2266961A2 (en) 2010-12-29
ES2380489T3 (es) 2012-05-14
TWI380981B (zh) 2013-01-01
US8008504B2 (en) 2011-08-30
WO2006135640A3 (en) 2007-08-02
DK2292607T3 (da) 2014-06-30
EP1896426A2 (en) 2008-03-12
US20100280257A1 (en) 2010-11-04
PT2266961E (pt) 2016-02-05
AU2011201044A1 (en) 2011-03-31
CA2611280C (en) 2014-01-28
AU2010241374A1 (en) 2010-12-02
EP2292607A2 (en) 2011-03-09
AU2010241374B2 (en) 2011-11-03
IN2014DN08588A (enExample) 2015-07-10
IN2014DN08578A (enExample) 2015-07-10
CN101189212B (zh) 2011-05-18
CA2942046A1 (en) 2006-12-21
AU2006258050A1 (en) 2006-12-21
CN102174020B (zh) 2012-11-07
KR20080014010A (ko) 2008-02-13
EP2292607B1 (en) 2014-04-09
PL2292607T3 (pl) 2014-09-30
EP2266961A3 (en) 2011-07-27
KR20120099028A (ko) 2012-09-06
EP2266961B1 (en) 2015-10-21
EP1896426B1 (en) 2012-01-11
DK2266961T3 (en) 2016-01-25
CA2886482A1 (en) 2006-12-21
KR101283109B1 (ko) 2013-07-05
ES2465522T3 (es) 2014-06-06
CA2886482C (en) 2017-09-05
CA2833394C (en) 2016-03-29
WO2006135640A2 (en) 2006-12-21
GT200600202AA (es) 2014-06-09
RU2007148238A (ru) 2009-07-20
CN102174019B (zh) 2013-02-13
PT2292607E (pt) 2014-06-24
MY146795A (en) 2012-09-28
BRPI0611683A2 (pt) 2010-09-28
CA2833394A1 (en) 2006-12-21
CN101189212A (zh) 2008-05-28
CN102180836B (zh) 2012-11-21
AR057056A1 (es) 2007-11-14
JP2008546645A (ja) 2008-12-25

Similar Documents

Publication Publication Date Title
PE20070109A1 (es) Procesos para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenamina
Jalani et al. Synthesis of substituted 1, 2, 3-triazoles via metal-free click cycloaddition reactions and alternative cyclization methods
MX2007003377A (es) Agonistas del receptor de trombopoyetina.
EA200870586A1 (ru) 3-(1,3-бензодиоксол-5-ил)-6-(4-циклопропилпиперазин-1-ил)пиридазин, его соли и сольваты и его применение в качестве антагониста н3 рецептора гистамина
PE20131086A1 (es) Proceso para preparar compuestos antivirales
YU44898A (sh) Postupak za dobijanje magnezijumove soli supstituisanog heterocikličnog sulfinila
CZ198598A3 (cs) Způsob přípravy imidazolových derivátů a meziprodukty tohoto postupu
WO2011019799A3 (en) Copper catalyzed cycloaddition of organic azides and 1-haloalkynes
Liu et al. Copper-catalyzed annulation of α-substituted diazoacetates with 2-ethynylanilines: the direct synthesis of C2-functionalized indoles
Tran et al. Copper-catalyzed domino three-component approach for the assembly of 2-Aminated benzimidazoles and quinazolines
PE20070015A1 (es) Proceso para la sintesis de compuestos pirimidinilaminobenzamidas
Khalili et al. KF/Al2O3: an efficient solid heterogeneous base catalyst in one-pot synthesis of benzimidazoles and bis-benzimidazoles at room temperature
Yi et al. Synthesis of 1, 2-Fused/Disubstituted Benzimidazoles and Benzimidazolium Salts by I2-Mediated sp3 C–H Amination
UY32242A (es) Ácidos de 2-[(1-cianopropil)carbamoil]-5-metoximetil nicotínico y su uso para la fabricación de imidazolinonas herbicidas
FR2843114B1 (fr) Procede de monomethylation d'heterocycles azotes
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
CA2482466A1 (en) Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
Talukdar et al. Ullmann-Type N-, S-, and O-Arylation Using a Well-Defined 7-Azaindole-N-oxide (7-AINO)-Based Copper (II) Catalyst: Scope and Application to Drug Synthesis
Łukasik et al. Aryliminophosphoranes as key intermediates in the one-pot synthesis of 1-aryl-1, 3-dihydro-2H-benzimidazol-2-ones from N-aryl-2-nitrosoanilines and carbon dioxide under mild metal-free conditions
ES8706116A1 (es) Un procedimiento para la preparacion de oxindol-carboxamidas triciclicas
YU52303A (sh) Postupak karbamoilacije alkohola
DE602006010584D1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
Rostamizadeh et al. Aqueous 1 M glucose solution as a novel and fully green reaction medium and catalyst for the oxidant-free synthesis of 2-arylbenzimidazoles
WO2009012201A3 (en) Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
PE20070084A1 (es) Proceso para la sintesis de 5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-bencenamina

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed